What is Boston Scientific Corp?
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 60.85B, and a P/E ratio of 18.2x.
A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 12,040 shares $100k |
| 3-6months | 0 | 5194,522 shares $9.4M |
| 6-9months | 0 | 49,800 shares $554k |
| 9-12months | 3178,214 shares $16.8M | 0 |
Openbook research
J&J beat on adjusted EPS and raised full-year guidance, yet the shares closed 5.73% lower at $248.61. MedTech growth of just 2.5% is the reason.
Kevin Lobo hands Stryker to Spencer Stiles on 1 January 2027. The shares fell just 2.46% to $278.20 — and part of that was not the succession at all.
Medtronic's 13.7% organic quarter included about 670bp from a 53rd fiscal week. The underlying rate is near 7%, and that is still the story.